Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.749 Q1 | 247 | 22 | 53 | 9201 | 1073 | 52 | 19.54 | 418.23 | |
2 | Pharmacology and Therapeutics | journal | 3.872 Q1 | 220 | 103 | 308 | 22992 | 3283 | 305 | 9.92 | 223.22 | |
3 | Food and Drug Law Journal | journal | 0.329 Q3 | 23 | 35 | 117 | 7167 | 62 | 117 | 0.57 | 204.77 | |
4 | Open Neuropsychopharmacology Journal | journal | 0.173 Q3 | 6 | 1 | 12 | 203 | 4 | 11 | 0.33 | 203.00 | |
5 | Medicinal Research Reviews | journal | 2.961 Q1 | 141 | 25 | 88 | 4452 | 878 | 87 | 10.10 | 178.08 | |
6 | Annual Review of Pharmacology and Toxicology | journal | 12.860 Q1 | 218 | 17 | 66 | 2944 | 1680 | 66 | 20.95 | 173.18 | |
7 | Natural Product Reports | journal | 3.020 Q1 | 200 | 83 | 210 | 13863 | 1691 | 201 | 7.76 | 167.02 | |
8 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.552 Q1 | 79 | 11 | 38 | 1827 | 176 | 38 | 3.84 | 166.09 | |
9 | Advances in Molecular Toxicology | book series | 0.153 Q4 | 17 | 8 | 16 | 1244 | 6 | 14 | 0.38 | 155.50 | |
10 | Frontiers in Medicinal Chemistry | book series | 0.119 Q4 | 7 | 15 | 29 | 2233 | 3 | 28 | 0.10 | 148.87 | |
11 | Antibiotics | journal | 61 | 1 | 0 | 140 | 0 | 0 | 0.00 | 140.00 | ||
12 | Critical Reviews in Toxicology | journal | 1.546 Q1 | 122 | 43 | 114 | 5878 | 624 | 106 | 4.83 | 136.70 | |
13 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.156 Q1 | 48 | 20 | 72 | 2718 | 220 | 72 | 3.10 | 135.90 | |
14 | Current Medicinal Chemistry | journal | 1.700 Q1 | 192 | 289 | 800 | 38208 | 4318 | 799 | 5.25 | 132.21 | |
15 | Drug Resistance Updates | journal | 5.328 Q1 | 125 | 19 | 49 | 2423 | 642 | 49 | 13.41 | 127.53 | |
16 | Recent Patents on CNS Drug Discovery | journal | 0.886 Q2 | 35 | 22 | 64 | 2758 | 190 | 64 | 2.88 | 125.36 | |
17 | Current Molecular Pharmacology | journal | 0.690 Q2 | 46 | 14 | 50 | 1728 | 117 | 50 | 2.34 | 123.43 | |
18 | Advanced Drug Delivery Reviews | journal | 4.742 Q1 | 348 | 127 | 396 | 15651 | 5671 | 347 | 13.82 | 123.24 | |
19 | Recent Advances in Anti-Infective Drug Discovery | journal | 35 | 21 | 65 | 2577 | 133 | 65 | 1.91 | 122.71 | ||
20 | RSC Drug Discovery Series | book series | 11 | 28 | 0 | 3295 | 0 | 0 | 0.00 | 117.68 | ||
21 | Drug Metabolism Reviews | journal | 1.371 Q1 | 105 | 39 | 93 | 4582 | 468 | 88 | 4.56 | 117.49 | |
22 | CNS and Neurological Disorders - Drug Targets | journal | 1.846 Q1 | 93 | 86 | 147 | 10049 | 654 | 130 | 3.62 | 116.85 | |
23 | Recent Advances in Drug Delivery and Formulation | journal | 38 | 18 | 63 | 2101 | 146 | 63 | 1.90 | 116.72 | ||
24 | Advances in Pharmacology | journal | 1.013 Q2 | 81 | 42 | 45 | 4899 | 108 | 38 | 1.55 | 116.64 | |
25 | Pharmacogenomics and Personalized Medicine | journal | 0.126 Q4 | 34 | 11 | 9 | 1260 | 3 | 9 | 0.33 | 114.55 | |
26 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.553 Q3 | 50 | 78 | 22 | 8855 | 48 | 21 | 1.13 | 113.53 | |
27 | Current Neuropharmacology | journal | 1.271 Q1 | 93 | 41 | 88 | 4630 | 324 | 85 | 3.46 | 112.93 | |
28 | Current Pharmaceutical Design | journal | 1.657 Q1 | 176 | 409 | 1056 | 45111 | 4989 | 943 | 4.84 | 110.30 | |
29 | Current Vascular Pharmacology | journal | 1.040 Q2 | 67 | 87 | 128 | 9547 | 456 | 119 | 3.66 | 109.74 | |
30 | Pharmakeftiki | journal | 0.101 Q4 | 5 | 2 | 29 | 219 | 0 | 28 | 0.00 | 109.50 | |
31 | Current Drug Metabolism | journal | 1.247 Q1 | 118 | 73 | 280 | 7949 | 1366 | 265 | 4.57 | 108.89 | |
32 | Current Drug Targets | journal | 1.356 Q1 | 112 | 159 | 397 | 17091 | 1364 | 355 | 3.07 | 107.49 | |
33 | Topics in Medicinal Chemistry | book series | 0.306 Q3 | 14 | 15 | 10 | 1612 | 7 | 8 | 0.70 | 107.47 | |
34 | Expert Opinion on Emerging Drugs | journal | 0.984 Q2 | 52 | 47 | 133 | 4968 | 469 | 133 | 3.90 | 105.70 | |
35 | Anti-Infective Agents | journal | 0.321 Q3 | 25 | 18 | 74 | 1885 | 73 | 71 | 0.98 | 104.72 | |
36 | Progress in Medicinal Chemistry | journal | 0.769 Q2 | 37 | 6 | 27 | 624 | 45 | 21 | 1.59 | 104.00 | |
37 | Current Pharmaceutical Analysis | journal | 0.503 Q2 | 26 | 23 | 91 | 2385 | 154 | 90 | 1.83 | 103.70 | |
38 | Expert Opinion on Therapeutic Targets | journal | 1.594 Q1 | 101 | 109 | 377 | 11083 | 1504 | 363 | 3.95 | 101.68 | |
39 | Current Gene Therapy | journal | 1.672 Q1 | 78 | 47 | 127 | 4735 | 653 | 123 | 4.98 | 100.74 | |
40 | Current Topics in Medicinal Chemistry | journal | 1.399 Q1 | 127 | 138 | 497 | 13860 | 1872 | 424 | 3.65 | 100.43 | |
41 | Open Pharmacology Journal | journal | 0.131 Q4 | 6 | 4 | 5 | 400 | 2 | 5 | 0.40 | 100.00 | |
42 | Expert Opinion on Drug Delivery | journal | 1.546 Q1 | 126 | 97 | 253 | 9623 | 1281 | 242 | 5.11 | 99.21 | |
43 | Handbook of Experimental Pharmacology | journal | 1.826 Q1 | 103 | 87 | 364 | 8617 | 1519 | 339 | 4.36 | 99.05 | |
44 | Pharmaceuticals | journal | 0.243 Q2 | 77 | 185 | 23 | 18278 | 15 | 22 | 0.65 | 98.80 | |
45 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.114 Q4 | 28 | 24 | 51 | 2355 | 19 | 51 | 0.37 | 98.13 | |
46 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q2 | 101 | 107 | 402 | 10462 | 1267 | 401 | 2.92 | 97.78 | |
47 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.148 Q4 | 26 | 37 | 109 | 3601 | 32 | 98 | 0.24 | 97.32 | |
48 | Inflammation and Allergy - Drug Targets | journal | 1.004 Q2 | 54 | 43 | 116 | 4170 | 408 | 113 | 3.51 | 96.98 | |
49 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.705 Q2 | 44 | 34 | 95 | 3265 | 206 | 93 | 1.97 | 96.03 | |
50 | Neurotherapeutics | journal | 2.320 Q1 | 129 | 53 | 220 | 4993 | 1468 | 206 | 6.84 | 94.21 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®